top of page
All Articles
Whistleblower Reports Raise Corruption Concerns over Pharmaceutical Giants’ Russian Cancer Drug Contracts
Confidential whistleblower reports have raised allegations that four major pharmaceutical companies paid substantial bonuses to Russian distributors involved in government medicine procurement, potentially creating financial incentives for corruption and contributing to higher prices for cancer treatments. The reports concern Merck, Eli Lilly, Novartis and AstraZeneca, which allegedly paid bonuses and rebates ranging from 15% to 35% to Russian distributors and sub-distributor
10 hours ago4 min read
bottom of page